Complementation of two mutant p53: Implications for loss of heterozygosity in cancer

被引:8
|
作者
Demidenko, ZN
Fojo, T
Blagosklonny, MV
机构
[1] New York Med Coll, Brander Canc Res Inst, Valhalla, NY 10595 USA
[2] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源
FEBS LETTERS | 2005年 / 579卷 / 10期
关键词
cancer; p53; tumor suppressor;
D O I
10.1016/j.febslet.2005.03.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Remarkably, a cancer cell rarely possesses two mutant p53 proteins. Instead, mutation of one allele is usually associated with loss of the second p53 allele. Why do not two mutant p53 co-exist? We hypothesize that two different p53 may complement each other, when expressed at equal levels. By titrating trans-deficient and DNA-binding-deficient p53 in cells with mutant p53 and by co-transfecting distinct mutant p53 in p53-null cells, we demonstrated activation of p53-dependent transcription. We suggest that, due to complementation of two mutant p53, cancer cells need to delete the second p53 allele rather than mutate it. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.Ni. All rights reserved.
引用
收藏
页码:2231 / 2235
页数:5
相关论文
共 50 条
  • [21] The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer
    Gleich, LL
    Li, YQ
    Biddinger, PW
    Gartside, PS
    Stambrook, PJ
    Pavelic, ZP
    Gluckman, JL
    LARYNGOSCOPE, 1996, 106 (11): : 1378 - 1381
  • [22] P53 MUTATIONS AND MICROSATELLITE ANALYSIS OF LOSS OF HETEROZYGOSITY IN MALIGNANT GLIOMAS
    TENAN, M
    COLOMBO, BM
    POLLO, B
    CAJOLA, L
    BROGGI, G
    FINOCCHIARO, G
    CANCER GENETICS AND CYTOGENETICS, 1994, 74 (02) : 139 - 143
  • [23] Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma
    Kato, MV
    Shimizu, T
    Ishizaki, K
    Kaneko, A
    Yandell, DW
    Toguchida, J
    Sasaki, MS
    CANCER LETTERS, 1996, 106 (01) : 75 - 82
  • [24] Pleomorphic carcinoma of the lung associated with loss of heterozygosity of p53 gene
    Arita, N
    Mikami, Y
    Yoshida, M
    Konishi, I
    Horiike, N
    Miyauchi, K
    Miyazaki, T
    Nose, M
    Ono, M
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 206 (02): : 181 - 185
  • [25] CANCER Mutant p53 and chromatin regulation
    Prives, Carol
    Lowe, Scott W.
    NATURE, 2015, 525 (7568) : 199 - 200
  • [26] The role of mutant p53 in human cancer
    Goh, Amanda M.
    Coffill, Cynthia R.
    Lane, David P.
    JOURNAL OF PATHOLOGY, 2011, 223 (02): : 116 - 126
  • [27] Chromosome instability contributes to loss of heterozygosity in mice lacking p53
    Shao, CS
    Deng, L
    Henegariu, O
    Liang, L
    Stambrook, PJ
    Tischfield, JA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) : 7405 - 7410
  • [28] LOSS OF HETEROZYGOSITY AND ANALYSIS OF MUTATION OF P53 IN HEPATOCELLULAR-CARCINOMA
    YUMOTO, Y
    HANAFUSA, T
    HADA, H
    MORITA, T
    OOGUCHI, S
    SHINJI, N
    MITANI, T
    HAMAYA, K
    KOIDE, N
    TSUJI, T
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1995, 10 (02) : 179 - 185
  • [29] Mutant p53 as a guardian of the cancer cell
    Mantovani, Fiamma
    Collavin, Licio
    Del Sal, Giannino
    CELL DEATH AND DIFFERENTIATION, 2019, 26 (02): : 199 - 212
  • [30] LOSS OF HETEROZYGOSITY AND OVEREXPRESSION OF THE P53 GENE IN OVARIAN-CARCINOMA
    FRANK, TS
    BARTOS, RE
    HAEFNER, HK
    ROBERTS, JA
    WILSON, MD
    HUBBELL, GP
    MODERN PATHOLOGY, 1994, 7 (01) : 3 - 8